From: Evidence for treatment with estradiol for women with SARS-CoV-2 infection
A.Estradiol usage cohort (♀ > 50 years old)
Patients in cohort
Odds ratio [95% CI]
Hazard ratio [95% CI]
User
439
0.33 [0.18, 0.62]
0.29 [0.11, 076]
Non-user
16,278